Telomere length in myelodysplastic syndromes

被引:45
|
作者
Rollison, Dana E. [1 ]
Epling-Burnette, P. K. [2 ]
Park, Jong Y. [1 ]
Lee, Ji-Hyun [1 ]
Park, Hyun [1 ]
Jonathan, Kristen [1 ]
Cole, Ashley L. [1 ]
Painter, Jeffrey S. [2 ]
Guerrier, Mayenha [2 ]
Melendez-Santiago, Johana [3 ]
Fulp, William [1 ]
Komrokji, Rami [4 ]
Lancet, Jeffrey [4 ]
List, Alan F. [4 ]
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Div Canc Prevent & Control, Tampa, FL 33682 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Program Immunol, Tampa, FL 33682 USA
[3] Univ S Florida, H Lee Moffitt Canc Ctr, Flow Cytometry Core Facil, Tampa, FL 33682 USA
[4] Univ S Florida, H Lee Moffitt Canc Ctr, Malignant Hematol Program, Tampa, FL 33682 USA
关键词
Myelodysplastic syndromes; telomere length; hTERT; WORLD-HEALTH-ORGANIZATION; CANCER RISK; MUTATIONS; GENE; CLASSIFICATION; ASSOCIATION; EXPOSURE; COHORT; BLOOD; CELLS;
D O I
10.3109/10428194.2011.568648
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between telomere length (TL) and predisposition to myelodysplastic syndromes (MDS) remains unclear. We compared peripheral blood leukocyte (PBL) TL among cases of histologically confirmed MDS (n = 65) who were treatment-naive with no prior cancer history to age-matched controls (n = 63). Relative TL was measured in PBLs and saliva by quantitative polymerase chain reaction (PCR) and in CD15+ and CD19+ cells by flow cytometry-fluorescence in situ hybridization (flow-FISH). Human telomerase reverse transcriptase gene (hTERT) mutations were assessed by PCR. After adjustment for age and sex, relative TLs were reduced in PBLs (p = 0.02), CD15+ (p = 0.01), CD19+ (p = 0.25), and saliva (p = 0.13) in MDS cases versus controls, although only the PBL and CD15+ results were statistically significant. Among MDS cases, CD15+ and CD19+ cell TLs were positively correlated (p = 0.03). PBL TL was reduced among those occupationally exposed to paints and pesticides, but was not associated with hTERT genotype. Future studies are needed to further investigate constitutional telomere attrition as a possible predisposing factor for MDS.
引用
收藏
页码:1528 / 1536
页数:9
相关论文
共 50 条
  • [31] Telomere Length: Implications for Atherogenesis
    Yin, Hao
    Pickering, J. Geoffrey
    CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (03) : 95 - 103
  • [32] Predicted leukocyte telomere length and risk of myeloid neoplasms
    Sullivan, Shannon M.
    Cole, Ben
    Lane, John
    Meredith, John J.
    Langer, Erica
    Hooten, Anthony J.
    Roesler, Michelle
    McGraw, Kathy L.
    Pankratz, Nathan
    Poynter, Jenny N.
    HUMAN MOLECULAR GENETICS, 2023, 32 (20) : 2996 - 3005
  • [33] Comparison of cytomorphology and histomorphology in myelodysplastic syndromes
    Nachtkamp, Kathrin
    Strupp, Corinna
    Faoro, Rosa
    Gattermann, Norbert
    Dietrich, Sascha
    Germing, Ulrich
    Baldus, Stefan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [34] Abnormal mRNA Expression Levels of Telomere-Binding Proteins Represent Biomarkers in Myelodysplastic Syndromes: A Case-Control Study
    Liu, Baoshan
    Yan, Rongdi
    Zhang, Jie
    Wang, Bin
    Sun, Hu
    Cui, Xing
    TURKISH JOURNAL OF HEMATOLOGY, 2017, 34 (03) : 200 - 206
  • [35] Defective ribosome biogenesis in myelodysplastic syndromes
    Galili, Naomi
    Qasim, Samir Ahmed
    Raza, Azra
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (10): : 1336 - 1338
  • [36] Updates in Risk Stratification in Myelodysplastic Syndromes
    Aguirre, Luis E.
    Sallman, David A.
    Stone, Richard
    Komrokji, Rami S.
    CANCER JOURNAL, 2023, 29 (03) : 138 - 142
  • [37] Telomere length is inherited with resetting of the telomere set-point
    Chiang, Y. Jeffrey
    Calado, Rodrigo T.
    Hathcock, Karen S.
    Lansdorp, Peter M.
    Young, Neal S.
    Hodes, Richard J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (22) : 10148 - 10153
  • [38] Myelodysplastic Syndromes and Metabolism
    Balaian, Ekaterina
    Wobus, Manja
    Bornhaeuser, Martin
    Chavakis, Triantafyllos
    Sockel, Katja
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (20)
  • [39] Overview of Myelodysplastic Syndromes
    Beris, Photis
    Georgiou, George
    SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 287 - 294
  • [40] Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes
    Chu, Sung-Chao
    Wang, Tso-Fu
    Li, Chi-Cheng
    Kao, Ruey-Ho
    Li, Dian-Kun
    Su, Yu-Chieh
    Wells, Denise A.
    Loken, Michael R.
    LEUKEMIA RESEARCH, 2011, 35 (07) : 868 - 873